The Munich-based chemical company WACKER acquires a 60 percent stake in specialty silane manufacturer SICO Performance Material Co., Ltd, Jining (China).
CureVac N.V., a company based in Tübingen, Germany, needs less production capacity for CVnCOV, its mRNA vaccine candidate against Covid-19.
Wacker Chemie AG closed Q2 2021 with significant increases in both sales and earnings.
As of the end of today’s Annual Share¬holders’ Meeting, Rudolf Staudigl (66), President and CEO of Wacker Chemie AG, retired from the company. As already announced, he was succeeded in that position by Christian Hartel (50).
Wacker Chemie AG finished Q1 2021 with significant growth in sales and earnings.
Creating Tomorrow's Solutions